Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome

Acta Derm Venereol. 2019 Jul 1;99(9):809-812. doi: 10.2340/00015555-3207.

Abstract

Tumor cells in cutaneous T-cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10 in mycosis fungoides, Sézary syndrome, lym-phomatoid papulosis and anaplastic large cell lymphoma in 121 skin biopsy samples. CXCR3 was expressed in 86% of mycosis fungoides cases but in no anaplastic large cell lymphoma cases. CCR3 was expressed in 73% of cases of CD30+ lymphoproliferative disorders such as lymphomatoid papulosis and anaplastic large cell lymphoma. Mycosis fungoides/Sézary syndrome patients with high CCR3 or CCR4 expression had a poorer survival prognosis than mycosis fungoides/Sézary syndrome patients whose tumor cells did not express these receptors. CCR10 was expressed in 50% of mycosis fungoides/Sézary syndrome cases and in 13% of cases with CD30+ lym-phoproliferative disorders. These results suggest that differential patterns of CXCR3, CCR3, CCR4 and CCR10 expression are useful for the diagnosis of cutaneous T-cell lymphoma. Moreover, expression of CCR3 or CCR4 suggests a poor prognosis in mycosis fungoides/Sézary syndrome.

Keywords: CCR10; CCR3; CCR4; CXCR3; CTCL.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Humans
  • Mycosis Fungoides / immunology*
  • Mycosis Fungoides / mortality
  • Mycosis Fungoides / pathology
  • Prognosis
  • Receptors, CCR10 / analysis
  • Receptors, CCR3 / analysis*
  • Receptors, CCR4 / analysis*
  • Receptors, CXCR3 / analysis
  • Sezary Syndrome / immunology*
  • Sezary Syndrome / mortality
  • Sezary Syndrome / pathology
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology
  • Up-Regulation

Substances

  • Biomarkers, Tumor
  • CCR10 protein, human
  • CCR3 protein, human
  • CCR4 protein, human
  • CXCR3 protein, human
  • Receptors, CCR10
  • Receptors, CCR3
  • Receptors, CCR4
  • Receptors, CXCR3